This information is intended for Canadian residents.
Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Links to comprehensive information about our pharmaceutical products are listed below, most frequently in the form of a product monograph.
This information has been approved by Health Canada and should be read and discussed in consultation with a health care professional.
AllStar® Pro
Apidra®
(insulin glulisine)
Demerol®
(meperidine hydrocholoride)
Glucophage®
Trademark of Merck Santé s.a.s. Commercialized in Canada by sanofi-aventis. (metformin hydrochloride)
Jevtana®
(cabazitaxel)
JuniorSTAR®
Kayexalate®
(sodium polystyrene sulfonate)
Lantus®
(insuline glargine)
- PRODUCT MONOGRAPH
- LANTUS® SOLOSTAR® INSTRUCTION LEAFLET
- SOLOSTAR® QUICK GUIDE
- LANTUS® REIMBURSEMENT IN QUEBEC
For more information, contact Sanofi Canada at 1-888-852-6887
Multaq®
(dronedarone tablets)
- PRODUCT MONOGRAPH
- RISK MINIMIZATION TOOL FOR HEALTHCARE PROFESSIONALS – CONTACT OUR MEDICAL INFORMATION DEPARTMENT
- SAFETY INFORMATION FOR THE PUBLIC - AUG. 4 2011 (PERMANENT ATRIAL FIBRILLATION)
- SAFETY INFORMATION FOR HEALTHCARE PROFESSIONALS - JULY 29 2011 (PERMANENT ATRIAL FIBRILLATION)
- SAFETY INFORMATION FOR THE PUBLIC - MARCH 15 2011 (LIVER INJURY)
- SAFETY INFORMATION FOR HEALTHCARE PROFESSIONALS - MARCH 10 2011 (HEPATOCELLULAR LIVER INJURY)
- INFORMATION FOR HEALTH PROFESSIONALS (PALLAS STUDY AND PULMONARY SAFETY)
- INFORMATION FOR THE PUBLIC (PALLAS STUDY)
Nitrolingual® Pumpspray
Trademark of G. Pohl-Boskamp GmbH & Co. Commercialized in Canada by sanofi-aventis. (nitroglycerin)
Novahistex® DH
(hydrocodone bitartrate, phenylephrine hydrochloride)
Plaquenil®
(hydroxychloroquine sulfate)
Sarclisa™
(isatuximab for injection)
Synvisc® /Synvisc-One®
(hylan G-F 20)
Toujeo® SoloSTAR® Toujeo®
DoubleSTAR®
(insulin glargine)